Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthace develops and commercializes a cloud-based digital experiment platform that enables life science researchers to design, automate, execute, and analyze complex experiments more efficiently. Their software supports assay development and high-throughput experimentation in drug discovery and bioprocessing. The platform has been adopted by leading pharmaceutical companies such as AstraZeneca, Oxford Biomedica, Syngenta, and Ipsen. In recent years the company has reported strong growth in recurring revenue and customer expansion among top global pharma firms. Synthace's technology helps standardize experimental workflows to improve reproducibility and accelerate scientific progress in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthace.